Invention Grant
- Patent Title: Anti-CD33 antibodies and methods of use thereof
-
Application No.: US15735946Application Date: 2016-06-11
-
Publication No.: US11174313B2Publication Date: 2021-11-16
- Inventor: Arnon Rosenthal , Kate Monroe , Francesca Avogadri-Connors
- Applicant: ALECTOR LLC
- Applicant Address: US CA South San Francisco
- Assignee: ALECTOR LLC
- Current Assignee: ALECTOR LLC
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- International Application: PCT/US2016/037109 WO 20160611
- International Announcement: WO2016/201389 WO 20161215
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; C12N15/62 ; C12N15/85 ; A61K39/00 ; A61P35/00

Abstract:
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
Public/Granted literature
- US20190085076A1 ANTI-CD33 ANTIBODIES AND METHODS OF USE THEREOF Public/Granted day:2019-03-21
Information query